Response to comments of Peter G. Mantle

Toxins

Volumn 2, Issue 10, 2010, Pages 2337-2339

  Schwartz, Gary G ^a   Manderville, Richard A ^b   Pfohl Leszkowicz, Annie ^c  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF GUELPH   (Canada)

^c UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

Dna adduct; Ochratoxin; Testicular cancer

Indexed keywords

OCHRATOXIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR MAB 3; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; CANCER RISK; CARCINOGENICITY; DNA ADDUCT; DRMT1 GENE; GENE EXPRESSION; GENE FUNCTION; GENE LOSS; GENE REPRESSION; GENETIC ASSOCIATION; NONHUMAN; PRENATAL EXPOSURE; PROGENY; SERTOLI CELL; SPERMATOGONIUM; TESTIS TUMOR; TUMOR SUPPRESSOR GENE;

MUS; RATTUS;

EID: 79952085968     PISSN: None     EISSN: 20726651     Source Type: Journal    
DOI: 10.3390/toxins2102337     Document Type: Article

References (11)

1. Jennings-Gee, J.E.; Tozlovanu, M.; Manderville, R.; Miller, M.S.; Pfohl-Leszkowicz, A.; Schwartz, G.G. Ochratoxin A: In utero exposure in mice induces adducts in testicular DNA. Toxins 2010, 2, 1428-1444.
2. Mantle, P.G.; Nolan, C.C. Pathological outcomes in kidney and brain in male Fischer rats given dietary ochratoxin A, commencing at one year of age. Toxins 2010, 2, 1100-1110.
3. Mantle, P.G.; Kulinskaya, E.; Nestler, S. Renal tumourigenesis in male rats in response to chronic dietary ochratoxin A. Food Addit. Contam. 2005, 22 (Suppl. 1), 58-64.
4. Knudsen, L.E.; Hansen, Å. Biomarkers of intermediate endpoints in environmental and occupational health. Int. J. Hyg. Environ. Health 2007, 210, 461-470.
5. Bonassi, S.; Neri, M.; Puntoni, R. Validation of biomarkers as early predictors of disease. Mutat. Res. 2001, 480-481, 349-358.
6. Pfohl-Leszkowicz, A. Formation, persistence and significance of DNA adduct formation in relation to some pollutants from a broad perspective. Adv. Mol. Toxicol. 2008, 2, 183-239.
7. Ueta, E.; Kodama, M.; Sumino, Y.; Kurome, M.; Ohta, K.; Katagiri, R.; Nauruse, I. Gender-dependent differences in the incidence of ochratoxin A-induced neural tube defects in the Pdn/Pdn mouse. Congenit. Anom. (Kyoto) 2010, 50, 29-39.
8. Murphy, M.W.; Sarver, A.L.; Rice, D.; Hatzi, K.; Ye, K.; Melnick, A.; Heckert, L.L.; Zarkower, D.; Bardwell, V.J. Genome-wide analysis of DNA binding and transcriptional regulation by the mammalian Doublesex homolog DMRT1 in the juvenile testis. Proc. Natl. Acad. Sci. USA 2010, 107, 13360-13365.
9. Krentz, A.; Murphy, M.W.; Kim, S.; Cook, M.S.; Capel, B.; Zhu, R.; Matin, A.; Sarver, A.L.; Parker, K.L.; Griswold, M.D.; Looijenga, L.H.J.; Bardwell, V.J.; Zarkower, D. The DM domain protein DMRT1 is a dose-sensitive regulator of fetal germ cell proliferation and pluripotency. Proc. Natl. Acad. Sci. USA 2009, 106, 22323-22328.
10. Turnbull, C.; Rapley, E.A.; Seal, S.; Pernet, D.; Renwick, A.; Hughes, D.; Ricketts, M.; Linger, R.; Nsengimana, J.; Deloukas, P.; et al. Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer. Nat. Genet. 2010, 42, 604-608.
11. Schwartz, G.G. Hypothesis: Does ochratoxin A cause testicular cancer? Cancer Causes Control 2002, 13, 91-100.